drugset / Trial / NCT00272467
Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy
Phase 4
Completed
132 enrolled
Korea Otsuka International Asia Arab
Korea Otsuka Pharmaceutical Co., Ltd. · collabZhejiang Otsuka Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the ulcer healing efficacy of rebamipide in comparison with omeprazole in Helicobacter pylori-positive gastric ulcer after eradication therapy.
Timeline
- Start
- 2005-07
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omeprazole | Other / unclassified | 20 mg | Oral |
| Subject | Rebamipide | Small molecule | 100 mg | Oral |